Press Releases

Valo & Charles River's Logica News: Charles River and Flagship’s Pioneering Medicines Enter Agreement Leveraging AI-Powered Logica with Aim of Creating Novel Therapies for Unmet Medical Needs

Valo Health to Present at the 41st Annual J.P. Morgan Healthcare Conference

Valo Health - FDA Collaborative Study in Human Cardiac Tissues Demonstrates Potential to Predict Clinical Efficacy of Cardiac Contractility Modulation Devices to Treat Heart Failure

Valo Health To Participate in Piper Sandler's 34th Annual Healthcare Conference

Valo's David Berry to Deliver Keynote at Founders Network's fnSummit 2022

KSM RESEARCH AND INNOVATION CENTER AND VALO HEALTH ANNOUNCE FIRST OF ITS KIND MULTIYEAR COLLABORATION TO SPEARHEAD PREVENTIVE CARE AND PERSONALIZED MEDICINE FOR PATIENTS

Valo Health to Participate in UBS Biotechnology Virtual Private Company Symposium

Valo Health To Participate in Citi's 17th Annual BioPharma Conference

Valo Announces First Patient Dosed in the OPL-0401 Phase 2 study of an oral ROCK1/2 inhibitor for the Treatment of Non-Proliferative Diabetic Retinopathy

Valo Health to Participate in June Conferences and Events

Valo Health Announces Publication of the Journal of Clinical Investigation of a New Therapeutic Approach to Improve CD8+ T Cell Function

Valo Health to Present at UBS Global Healthcare Conference 2022

Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform

Valo Health to Present at Oppenheimer 32nd Annual Healthcare Conference

Valo Health CEO David Berry to Participate in 2022 BIO CEO & Investor Conference

Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions

Valo Health Names Dave Morris Chief Medical Officer

Valo Health to Present at the 40th Annual J.P. Morgan Healthcare Conference

David Berry to Participate in NewYorkBio and New York Stock Exchange Emerging Biotech Company Showcase

Valo Health and Khosla Ventures Acquisition Co. Mutually Agree to Terminate Business Combination Agreement

Valo Health and Khosla Ventures Acquisition Co. Announce Additional PIPE Commitments

Valo Health to Participate in Piper Sandler and Goldman Sachs Investor Conferences

Valo Health Appoints Joe Chan as Head of Engineering